ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

20,542Medicare Part D Prescriptions Filled, Including Refills

Rank: 89 out of 2888

$1.35M Total Retail Price of All Prescriptions

Rank: 95 out of 2888

863 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

17% of this provider’s 863 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

4% of this provider’s 16,999 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METFORMIN HCL 845 711 1 8
SIMVASTATIN 802 690 2 2
METOPROLOL SUCCINATE 766 684 3 11
ENALAPRIL MALEATE 708 550 4 49
HYDROCHLOROTHIAZIDE 624 547 5 15
NEXIUM 525 410 6 19
LEVOTHYROXINE SODIUM 518 449 7 1
IBUPROFEN 504 384 8 87
ALENDRONATE SODIUM 403 354 9 23
DIOVAN 398 389 10 35
AMLODIPINE BESYLATE 393 315 11 5
JANUVIA 384 359 12 48
ATORVASTATIN CALCIUM 382 306 13 9
CRESTOR 340 273 14 20
LISINOPRIL 333 271 15 3
FUROSEMIDE 310 295 16 6
PRAVASTATIN SODIUM 273 230 17 12
AZITHROMYCIN 249 195 18 38
ACTOS 249 221 18 108
OMEPRAZOLE 239 207 20 7
DONEPEZIL HCL 237 221 21 26
HYDROCODONE-ACETAMINOPHEN 236 176 S3 22 4
ZOLPIDEM TARTRATE 224 168 23 17
LOSARTAN POTASSIUM 216 174 24 18
NAMENDA 213 211 25 34
TRAMADOL HCL 196 183 26 16
METOPROLOL TARTRATE 194 187 27 10
ZETIA 192 152 28 81
GLIPIZIDE ER 190 173 29 107
TAMSULOSIN HCL 190 169 29 29
CLONIDINE HCL 172 159 31 39
GLYBURIDE 162 138 R 32 58
AMOX TR-POTASSIUM CLAVULANATE 159 115 33 112
GLYBURIDE-METFORMIN HCL 159 127 R 33 64
WARFARIN SODIUM 150 109 35 22
INSULIN SYRINGE 133 111 36 86
IBANDRONATE SODIUM 129 125 37 272
DIOVAN HCT 125 89 38 61
SERTRALINE HCL 117 92 39 27
LOVAZA 117 77 39 97
MECLIZINE HCL 116 93 41 122
CLOPIDOGREL 115 99 42 30
GABAPENTIN 112 108 43 13
ACETAMINOPHEN-CODEINE 111 79 S3 44 147
LIPITOR 108 82 45 78
LACTULOSE 108 92 45 111
TRILIPIX 108 66 45 160
HYDRALAZINE HCL 106 86 48 59
ALLOPURINOL 106 87 48 37
PLAVIX 103 81 50 40
PANTOPRAZOLE SODIUM 102 94 51 33
LEVOFLOXACIN 101 85 52 57
PIOGLITAZONE HCL 101 85 R 52 248
LOSARTAN-HYDROCHLOROTHIAZIDE 98 96 54 46
NASONEX 95 60 55 168
ACTONEL 94 94 56 149
GLIPIZIDE XL 94 79 56 205
MIRTAZAPINE 92 68 58 54
ATENOLOL 91 49 59 25
LANTUS 90 65 60 45
CLOTRIMAZOLE-BETAMETHASONE 87 75 61 136
VOLTAREN 85 76 62 157
NOVOLIN 70-30 83 70 63 144
METHYLPREDNISOLONE 79 67 64 101
NOVOLIN N 77 72 65 255
CYCLOBENZAPRINE HCL 76 62 R 66 68
METAXALONE 72 61 R 67 516
CITALOPRAM HBR 71 68 68 24
METFORMIN HCL ER 71 56 68 53
GEMFIBROZIL 70 45 70 98
NORTRIPTYLINE HCL 69 57 71 263
NITROFURANTOIN MONO-MACRO 67 58 72 162
CARVEDILOL 66 39 73 21
DETROL LA 64 64 74 192
LYRICA 63 50 75 69
PROMETHAZINE HCL 60 43 R 76 96
FENOFIBRATE 58 51 77 65
RANITIDINE HCL 57 49 78 56
ANTARA 56 53 79 395
PROAIR HFA 55 45 80 71
BONIVA 54 47 81 319
FLUTICASONE PROPIONATE 53 46 82 32
ISOSORBIDE MONONITRATE ER 51 43 83 51
FLUOXETINE HCL 50 31 84 83
SPIRIVA 50 31 84 79
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 30, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.